Ablatus secures £500,000 in private finance deal

Our recent work with Innovate UK EDGE innovation and growth specialist Emma Douglas-Beet has helped Ablatus to find the £500,000 match funding it needed to secure an Innovate UK Smart Grant of £1.42 million. Fundraising activity continues alongside ongoing product development. The funds were required for final pre-clinical testing and to create a pre-commercialisation product […]

Ablatus shortlisted for coveted #21toWatch Awards

The 2021 shortlist for the coveted #21toWatch Awards was revealed earlier this week and Ablatus are delighted to have made it onto the shortlist for the prestigious ‘Things’ Award. The list includes some of the most inspirational entrepreneurs, start-ups and innovations from the East of England and being named on the shortlist is a real […]

David Lewis joins Ablatus as CEO

We are delighted to announce the appointment of David Lewis as CEO at Ablatus Therapeutics Ltd.  David has a strong history of delivery within the global medical technology space, having started his career with Johnson & Johnson and CR Bard. David then spent 15 years at Medtronic, holding progressive Senior Leadership roles, which culminated in […]

Ablatus awarded £1M Innovate UK grant

We are delighted to have been awarded over £1M by the UK government to develop our novel minimally invasive treatment for soft tissue tumours.  The award will fund a 2-year project to develop the protype device into a final version for use in patients for the first time. Partnering with Cambridge-based product engineering and design […]

Ablatus Therapeutics receives first CE Mark for Bimodal Electric Tissue Ablation system component

We are delighted to announce that we have received our first CE mark! Our surgical ablation system offers significant advantage over the current standard of care across a variety of therapeutic indications. One of the components of the system is a patient grounding pad which facilitates energy delivery into the targeted tissue. The CE Mark […]

Ablatus Therapeutics achieves ISO 13485:2016 certification

Ablatus has been certified to ISO 13485:2016 following successful audits with BSI. ISO 13485 is a global standard in quality management systems for medical devices that supports polices and processes across the entire business. CEO David Brooks said: “As we continue development of our technology for clinical use, conforming to the ISO 13485 standard is […]

Ablatus reaches final of east of England Investment Catalyst Pitching Day

We are delighted to announce that David Brooks, our CEO, successfully pitched to a panel of investors on 31st October and won a spot at the prestigious final of the East of England Investment Catalyst Pitching Day. David saw off stiff competition from 10 other companies from the Cambridge area and now benefits bespoke support […]

Article in Medical Technology

We are delighted to be in print in issue 18 of Medical Technology. The article is entitled ‘Destroying tumours with next-generation ablation’, here’s brief intro, click here to read the full article. “Radiofrequency ablation (RFA) can destroy solid tumours without the need for invasive surgery. At the forefront is NHS Norfolk and Norwich University Hospital […]

Healthcare revolution: The ten health innovations that could soon be on the NHS

In the 70 years since the NHS was established, medical breakthroughs such as MRI scanners, IVF and dialysis machines have transformed the health service and people’s lives. And while it’s impossible to predict how things will change over the next seven decades experts such as NHS England’s health innovation chief Professor Tony Young are predicting […]

Award nomination for New Anglia Capital investee Ablatus

Norfolk and Norwich University Hospital spin-out Ablatus Therapeutics has been shortlisted for the esteemed UK Business Angels Association (UKBAA) Angel Investment Awards. The awards will celebrate 2018’s high-growth entrepreneur success stories and the investors behind them and will be presented at a glittering ceremony on 19th June, in Liverpool Cathedral. Ablation uses heat generated by electric […]